Page last updated: 2024-10-18

dihydroxyphenylalanine and Myxedema

dihydroxyphenylalanine has been researched along with Myxedema in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hodkinson, HM1

Reviews

1 review available for dihydroxyphenylalanine and Myxedema

ArticleYear
Advances in geriatrics.
    The Practitioner, 1972, Volume: 209, Issue:252

    Topics: Aged; Amantadine; Diet Therapy; Dihydroxyphenylalanine; Diverticulum, Colon; Drug-Related Side Effec

1972